A low molecular weight heparin (enoxaparin, mean molecular weight ~ 4,400) was separated by gel chromatography into eight different fractions with a narrow distribution around the following mean molecular weights: 1,800, 2,400, 2,900, 4,200, 6,200, 8,600, 9,800 and 11,000. We compared the influence of enoxaparin on the generation of thrombin in plasma to that of the eight fractions. We determined: a) the % of material with high affinity to antithrombin III (HAM) and the % of HAM above the critical chainlength necessary to allow for thrombin inhibition (ACLM), b) the specific catalytic activity on the decay of endogenous thrombin, and c) the inhibition of over-all thrombin formation in the extrinsic and the intrinsic pathway. From b and c we...
Despite the well-established medical use of heparins, the question arises whether the efficacy-safet...
We studied the mode of action of the low molecular weight heparin PK10169 and two of its constituent...
Heparins inhibit the thrombin forming capacity of plasma, i. e., the endogenous thrombin potential (...
A low molecular weight heparin (enoxaparin, mean molecular weight ~ 4,400) was separated by gel chro...
Three fractions of the low molecular weight heparin CY2l6 (fraxiparin, mean molecular weight [MMW] 5...
Three fractions of the low molecular weight heparin CY216 (fraxiparin, mean molecular weight [MMW] 5...
Background: Heparins in clinical use differ considerably as to mode of preparation, molecular weight...
Low molecular weight (LMW) heparin preparations have unknown distributions of ATIII-binding material...
Abstract. Heparins ' unfractionated and low molecular weight, act primarily by their scav-engin...
The paper discusses the non-anticoagulant properties of unfractionated heparin and enoxaparin and th...
Heparin consists of different classes of molecules. We distinguish below-critical-chain length hepar...
Heparin consists of different classes of molecules. We distinguish below-critical-chain length hepar...
Sulphated hyaluronic acids having a sulphation degree of 3.5 per disaccharide unit, HyalS3.5, were p...
We investigated whether the inactivation of factor IXa contributes to the partial inhibition of thro...
Despite the well-established medical use of heparins, the question arises whether the efficacy-safet...
We studied the mode of action of the low molecular weight heparin PK10169 and two of its constituent...
Heparins inhibit the thrombin forming capacity of plasma, i. e., the endogenous thrombin potential (...
A low molecular weight heparin (enoxaparin, mean molecular weight ~ 4,400) was separated by gel chro...
Three fractions of the low molecular weight heparin CY2l6 (fraxiparin, mean molecular weight [MMW] 5...
Three fractions of the low molecular weight heparin CY216 (fraxiparin, mean molecular weight [MMW] 5...
Background: Heparins in clinical use differ considerably as to mode of preparation, molecular weight...
Low molecular weight (LMW) heparin preparations have unknown distributions of ATIII-binding material...
Abstract. Heparins ' unfractionated and low molecular weight, act primarily by their scav-engin...
The paper discusses the non-anticoagulant properties of unfractionated heparin and enoxaparin and th...
Heparin consists of different classes of molecules. We distinguish below-critical-chain length hepar...
Heparin consists of different classes of molecules. We distinguish below-critical-chain length hepar...
Sulphated hyaluronic acids having a sulphation degree of 3.5 per disaccharide unit, HyalS3.5, were p...
We investigated whether the inactivation of factor IXa contributes to the partial inhibition of thro...
Despite the well-established medical use of heparins, the question arises whether the efficacy-safet...
We studied the mode of action of the low molecular weight heparin PK10169 and two of its constituent...
Heparins inhibit the thrombin forming capacity of plasma, i. e., the endogenous thrombin potential (...